Procaps Group, S.A. (PROCW)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2022 | 409.92 Million USD | 0.04% |
| 2021 | 409.74 Million USD | 23.61% |
| 2020 | 331.46 Million USD | 2.06% |
| 2019 | 324.79 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q1 | 84.16 Million USD | -17.05% |
| 2023 Q3 | 118.41 Million USD | 7.59% |
| 2023 Q2 | 110.05 Million USD | 30.77% |
| 2022 FY | 409.92 Million USD | 0.04% |
| 2022 Q4 | 101.46 Million USD | -8.09% |
| 2022 Q3 | 110.4 Million USD | -1.79% |
| 2022 Q2 | 112.42 Million USD | 31.29% |
| 2022 Q1 | 85.63 Million USD | -32.33% |
| 2021 Q1 | 77.44 Million USD | -34.45% |
| 2021 FY | 409.74 Million USD | 23.61% |
| 2021 Q2 | 98.93 Million USD | 27.75% |
| 2021 Q4 | 126.53 Million USD | 18.45% |
| 2021 Q3 | 106.82 Million USD | 7.98% |
| 2020 Q4 | 118.14 Million USD | 48.96% |
| 2020 Q3 | 79.31 Million USD | -3.16% |
| 2020 Q1 | 52.11 Million USD | 0.0% |
| 2020 FY | 331.46 Million USD | 2.06% |
| 2020 Q2 | 81.89 Million USD | 57.16% |
| 2019 FY | 324.79 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 566.76 Million USD | 27.674% |
| China SXT Pharmaceuticals, Inc. | 1.92 Million USD | -21155.931% |
| Embecta Corp. | 1.12 Billion USD | 63.426% |
| Pacira BioSciences, Inc. | 674.97 Million USD | 39.269% |
| PainReform Ltd. | - USD | -Infinity% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -1601.422% |
| SCYNEXIS, Inc. | 140.14 Million USD | -192.505% |
| Journey Medical Corporation | 79.18 Million USD | -417.7% |
| Safety Shot Inc | 202.67 Thousand USD | -202159.831% |
| Alpha Teknova, Inc. | 36.68 Million USD | -1017.435% |
| Bright Green Corporation | 401.49 Thousand USD | -101999.424% |
| Alvotech | 91.43 Million USD | -348.323% |
| ANI Pharmaceuticals, Inc. | 486.81 Million USD | 15.796% |
| Aquestive Therapeutics, Inc. | 50.58 Million USD | -710.391% |
| Cosmos Health Inc. | 53.37 Million USD | -667.973% |
| Dynavax Technologies Corporation | 232.28 Million USD | -76.474% |
| Esperion Therapeutics, Inc. | 116.33 Million USD | -252.365% |
| Intra-Cellular Therapies, Inc. | 464.37 Million USD | 11.726% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -1601.422% |
| Theratechnologies Inc. | 81.76 Million USD | -401.345% |
| Harrow Health, Inc. | 130.19 Million USD | -214.856% |
| Sonoma Pharmaceuticals, Inc. | 12.73 Million USD | -3118.846% |
| Biofrontera Inc. | 34.07 Million USD | -1103.135% |
| DURECT Corporation | 8.54 Million USD | -4695.508% |
| Supernus Pharmaceuticals, Inc. | 607.52 Million USD | 32.526% |
| Cronos Group Inc. | 88.84 Million USD | -361.409% |
| OptiNose, Inc. | 70.98 Million USD | -477.458% |
| Ironwood Pharmaceuticals, Inc. | 442.73 Million USD | 7.412% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 6.51 Million USD | -6193.707% |
| Organogenesis Holdings Inc. | 433.14 Million USD | 5.361% |
| Guardion Health Sciences, Inc. | 12.24 Million USD | -3246.682% |
| Cumberland Pharmaceuticals Inc. | 39.55 Million USD | -936.394% |
| Radius Health, Inc. | 2.88 Billion USD | 85.778% |
| Universe Pharmaceuticals INC | 32.3 Million USD | -1168.759% |
| ProPhase Labs, Inc. | 44.38 Million USD | -823.576% |
| Phibro Animal Health Corporation | 1.01 Billion USD | 59.72% |
| Procaps Group S.A. | 409.92 Million USD | 0.0% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -31383.871% |
| Viatris Inc. | 15.42 Billion USD | 97.343% |
| Rockwell Medical, Inc. | 83.61 Million USD | -390.265% |
| Aytu BioPharma, Inc. | 81 Million USD | -406.062% |
| SIGA Technologies, Inc. | 139.91 Million USD | -192.973% |
| Tilray Brands, Inc. | 788.94 Million USD | 48.042% |
| Lifecore Biomedical, Inc. | 128.26 Million USD | -219.598% |
| Shineco, Inc. | 9.8 Million USD | -4082.065% |
| PetIQ, Inc. | 1.1 Billion USD | 62.801% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 12 Thousand USD | -3415900.0% |
| Neurocrine Biosciences, Inc. | 1.88 Billion USD | 78.278% |
| Alimera Sciences, Inc. | 80.75 Million USD | -407.616% |
| Silver Spike Investment Corp. | 11.72 Million USD | -3396.974% |
| Assertio Holdings, Inc. | 152.06 Million USD | -169.562% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 5.82 Million USD | -6940.41% |
| Clever Leaves Holdings Inc. | 17.41 Million USD | -2253.563% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -37982.32% |
| Avadel Pharmaceuticals plc | 27.96 Million USD | -1365.937% |
| Hempacco Co., Inc. | 4.04 Million USD | -10032.397% |
| Talphera, Inc. | 651 Thousand USD | -62867.742% |
| Alvotech | 91.43 Million USD | -348.323% |
| Eagle Pharmaceuticals, Inc. | 316.61 Million USD | -29.472% |
| Lantheus Holdings, Inc. | 1.29 Billion USD | 68.381% |
| Currenc Group, Inc. | 53.25 Million USD | -669.725% |
| Kamada Ltd. | 144.75 Million USD | -183.175% |
| Indivior PLC | 1.09 Billion USD | 62.496% |
| Evoke Pharma, Inc. | 5.18 Million USD | -7812.551% |
| Flora Growth Corp. | 76.07 Million USD | -438.865% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -37982.32% |
| Evolus, Inc. | 202.08 Million USD | -102.845% |
| HUTCHMED (China) Limited | 837.99 Million USD | 51.083% |
| Amphastar Pharmaceuticals, Inc. | 644.39 Million USD | 36.387% |
| Akanda Corp. | 2.16 Million USD | -18877.321% |